Quantcast
News

College Hockey:
Wednesday Transplant Scheduled for Yale’s Schwartz

Doctors have set Wednesday as the day for a stem-cell transplant for Yale center Mandi Schwartz.

That news came in an update on the Yale page dedicated to Schwartz’s battle with acute myeloid lymphoma.

Schwartz had been scheduled for the transplant earlier, but that had to be postponed because she was no longer in remission.

She is scheduled for chemotherapy on Sunday and Monday to ensure that all of the existing cancerous cells in her body are eliminated and suppress her immune system to prevent her body from rejecting the donor cells.

“The scheduling of the transplant gives us reason for optimism,” Rick Schwartz, Mandi’s father, told the Yale website. “Mandi has kept up a positive attitude throughout this whole process, and we are looking forward to the day when she can be declared cancer-free.

“We continue to be thankful for all the support that we have received, and for the efforts of the doctors at the Seattle Cancer Care Alliance. Please continue raising awareness of the need for bone marrow donors and umbilical cord blood donors to save the lives of all patients who need transplants like the one Mandi will receive.”

For more, visit Yale’s latest update.


The following is a self-policing forum for discussing views on this story. Comments that are derogatory, make personal attacks, are abusive, or contain profanity or racism will be removed at our discretion. USCHO.com is not responsible for comments posted by users. Please report any inappropriate or offensive comments by clicking the “Flag” link next to that comment in order to alert the moderator.

Please also keep “woofing,” taunting, and otherwise unsportsmanlike behavior to a minimum. Your posts will more than likely be deleted, and worse yet, you reflect badly on yourself, your favorite team and your conference.

BNY Mellon Wealth Management